HI
NBIX icon

Handelsinvest Investeringsforvaltning’s Neurocrine Biosciences NBIX Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$309K Sell
2,241
-1,164
-34% -$159K 0.15% 161
2023
Q4 		$449K Buy
+3,405
New +$392K 0.18% 152
2020
Q4 		– Sell
-45,000
Closed -$4.33M – 125
2020
Q3 		$4.33M Buy
45,000
+10,000
+29% +$1.16M 0.82% 46
2020
Q2 		$4.27M Sell
35,000
-5,000
-13% -$553K 0.89% 41
2020
Q1 		$3.46M Hold
40,000
– – 0.92% 44
2019
Q4 		$4.3M Sell
40,000
-10,000
-20% -$1.05M 0.86% 40
2019
Q3 		$4.51M Buy
50,000
+5,600
+13% +$523K 0.99% 36
2019
Q2 		$3.75M Hold
44,400
– – 0.79% 39
2019
Q1 		$3.91M Hold
44,400
– – 0.87% 38
2018
Q4 		$3.17M Hold
44,400
– – 0.79% 44
2018
Q3 		$5.46M Hold
44,400
– – 1.12% 34
2018
Q2 		$4.36M Hold
44,400
– – 0.96% 40
2018
Q1 		$3.68M Hold
44,400
– – 0.82% 42
2017
Q4 		$3.44M Hold
44,400
– – 0.76% 40
2017
Q3 		$2.72M Hold
44,400
– – 0.64% 40
2017
Q2 		$2.04M Buy
44,400
+24,700
+125% +$1.2M 0.51% 46
2017
Q1 		$853K Buy
19,700
+5,000
+34% +$214K 0.24% 82
2016
Q4 		$569K Hold
14,700
– – 0.2% 81
2016
Q3 		$744K Buy
+14,700
New +$732K 0.27% 81

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's NBIX Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Neurocrine Biosciences (NBIX) stake by 34% in Q1 2024, selling an estimated $159K and leaving 2,241 shares worth $309K. The position accounts for 0.15% of the portfolio, ranked #161.

Handelsinvest Investeringsforvaltning first reported a position in NBIX in Q3 2016 and has held it in 19 quarters since. The position peaked at $5.46M in Q3 2018. 590 funds tracked by Wall St. Rank hold NBIX as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 2,241 shares of Neurocrine Biosciences worth $309K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 1,164 Neurocrine Biosciences shares in Q1 2024, an estimated $159K.
  • Neurocrine Biosciences made up 0.15% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #161 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Neurocrine Biosciences in Q3 2016 and has held it in 19 quarters since.
  • Handelsinvest Investeringsforvaltning's Neurocrine Biosciences position peaked at $5.46M in Q3 2018.
  • 590 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.